09.01.2013 Views

Oral Presentations - Federation of Clinical Immunology Societies

Oral Presentations - Federation of Clinical Immunology Societies

Oral Presentations - Federation of Clinical Immunology Societies

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

S34 Abstracts<br />

University, Maidashi, Japan, Tadashi Matsuda, Pr<strong>of</strong>essor,<br />

Department <strong>of</strong> <strong>Immunology</strong>, Graduate School <strong>of</strong> Pharmaceutical<br />

Sciences Hokkaido University, Sapporo, Japan<br />

Signal transducing adaptor protein-2 (STAP-2) is a recently<br />

identified adaptor protein, which contains pleckstrin homology<br />

(PH) and Src homology 2 (SH2)-like domains as well as a prolinerich<br />

domain in its C-terminal region. Our previous studies have<br />

demonstrated that STAP-2 binds to MyD88 and IKK-α/β, and<br />

modulates NF-kappaB signaling in macrophages. In this study,<br />

STAP-2 was induced by expression <strong>of</strong> the Epstein–Barr virus LMP1<br />

in B cells, while overexpression <strong>of</strong> STAP-2 inhibited LMP1mediated<br />

NF-kappaB signaling. Furthermore, STAP-2 associated<br />

with LMP1 in EBV-positive B cells. These results strongly suggest<br />

that STAP-2 acts as an endogenous negative inhibitor <strong>of</strong> the EBV<br />

LMP1-mediated signaling, which is critical for the EBV persistent<br />

infection and EBV-associated pathogenesis.<br />

doi:10.1016/j.clim.2007.03.273<br />

F.61 Defensins Block Bacterial Toxin-induced<br />

Interleukin-1β Production<br />

Jishu Shi, Assistant Pr<strong>of</strong>essor, Anatomy, Physiology and<br />

Pharmacology, Auburn, AL, Shelly Ao, Research Assistant,<br />

APP, Auburn, AL, Charalabos Pathoulakis, Pr<strong>of</strong>essor,<br />

Gasterenterology, Boston, MA<br />

This study was designed to test the hypothesis that<br />

defensins can block the release <strong>of</strong> IL-1β induced by<br />

Clostridium difficile toxin A (TxA) and Staphylococcus<br />

aureus α-toxin (a-Tox). LPS-activated (20 ng/ml, 2 h)<br />

human monocytes were treated with 3 nM TxA in the<br />

presence or absence <strong>of</strong> human neutrophil defensin HNP-1<br />

(25–50 μg/ml) or human Paneth cell defensin HD-5 (25–50<br />

μg/ml) for 6 h. In the absence <strong>of</strong> defensins, TxAstimulated<br />

monocytes released a large amount <strong>of</strong> mature<br />

IL-1β (17 kDa) into the extracellular milieu. The release<br />

<strong>of</strong> mature IL-1β from TxA-stimulated monocytes was<br />

blocked by HNP-1 and HD-5 in a dose-dependent manner.<br />

Different from ATP, TxA-induced IL-1β release was not<br />

inhibited by KN-62, a P2X7 receptor antagonist. In<br />

contrast to TxA, a-Tox (250 ng/ml) induced the release<br />

<strong>of</strong> both proIL-1β (31 kDa) and mature IL-1β from LPSactivated<br />

monocytes. In the presence <strong>of</strong> 20 μg/ml <strong>of</strong><br />

HNP-1 or HD-5, the amount <strong>of</strong> mature IL-1β released from<br />

a-Tox-treated monocytes was reduced by 70%, while a-<br />

Tox-induced release <strong>of</strong> proIL-1β was completely blocked.<br />

Similar to TxA, a-Tox-induced IL-1β release was not<br />

inhibited by KN-62. Furthermore, the release <strong>of</strong> mature<br />

IL-1β was caspase-1-dependent for both toxins. These<br />

data suggest that TxA- and a-Tox-induced IL-1β release is<br />

independent <strong>of</strong> the ATP/P2X7 receptor pathway, and that<br />

defensins can block bacterial toxin-induced posttranslational<br />

processing and release <strong>of</strong> IL-1β. In addition to their<br />

antimicrobial activity, defensins may play an important<br />

role in host inflammatory response to bacterial infection<br />

by controlling the production <strong>of</strong> IL-1β.<br />

doi:10.1016/j.clim.2007.03.274<br />

F.62 Lack <strong>of</strong> Association <strong>of</strong> Interleukin-8 Gene<br />

Polymorphism with Helicobacter Pylori-induced<br />

Gastritis in Iranian Patients<br />

Ayda Hosseinkhani, Pharmacist, <strong>Clinical</strong> Microbiology<br />

Research Center, Shiraz University <strong>of</strong> Medical Sciences,<br />

Shiraz, Iran, Farshad Shohreh, Microbiologist, <strong>Clinical</strong><br />

Microbiology Research Center, Shiraz University <strong>of</strong> Medical<br />

Sciences, Shiraz, Iran, Akram Jamshidzadeh, PhD, Faculty <strong>of</strong><br />

Pharmacy-Shiraz University <strong>of</strong> Medical Sciences, Shiraz,<br />

Iran, Manoochehr Rasouli, PhD, <strong>Clinical</strong> Microbiology<br />

Research Center, Shiraz University <strong>of</strong> Medical Sciences,<br />

Shiraz, Iran, Simin Kiany, MSc, <strong>Clinical</strong> Microbiology<br />

Research Center, Shiraz University <strong>of</strong> Medical Sciences,<br />

Shiraz, Iran<br />

Background: Helicobacter pylori is a major cause <strong>of</strong><br />

neoplastic and inflammatory gastroduodenal diseases <strong>of</strong> the<br />

stomach. H. pylori infection and associated gastric diseases are<br />

common in developing countries. Cytokine gene polymorphisms<br />

and H. pylori have been linked to gastric disease. We determined<br />

the role <strong>of</strong> host interleukin-8 (−251 A/T) gene polymorphism in<br />

the development <strong>of</strong> gastritis in south Iranian population.<br />

Methods: We genotyped IL-8 (−251 A/T) gene polymorphism in<br />

54 H. pylori infected individuals with gastritis and 337 infected<br />

individuals with normal mucosa using polymerase chain reaction-restriction<br />

fragment length polymorphism (PCR-RFLP). The<br />

diagnosis <strong>of</strong> gastritis was established on the basis <strong>of</strong> endoscopic<br />

findings.<br />

Results: We did not find any significant differences in<br />

allele and genotype frequencies <strong>of</strong> IL-8 (−251A/T) among our<br />

study groups. Discussion: Our analysis did not reveal a<br />

significant difference between the frequencies <strong>of</strong> IL-8<br />

(−251) genotypes and alleles which might be the result <strong>of</strong><br />

our limited number <strong>of</strong> patient population. We suggest this<br />

study be continued on larger population <strong>of</strong> the patients. Also,<br />

analysis <strong>of</strong> polymorphism in other positions <strong>of</strong> IL-8 gene is<br />

recommended.<br />

doi:10.1016/j.clim.2007.03.275<br />

F.63 The Impact <strong>of</strong> HLA Polymorphisms on<br />

Measles Virus-specific T-Cell Memory Responses<br />

in Vaccinated Subjects<br />

Inna Ovsyannikova, Senior Research Associate, Mayo Clinic,<br />

Mayo Vaccine Research Group, Rochester, MN, Jenna Ryan,<br />

Senior Research Technologist, Mayo Clinic, Mayo Vaccine<br />

Research Group, Rochester, MN, Norman Pinsky, Senior<br />

Research Technologist, Mayo Clinic, Mayo Vaccine Research<br />

Group, Rochester, MN, Robert Jacobson, Pr<strong>of</strong>essor <strong>of</strong><br />

Pediatrics, Mayo Clinic, Department <strong>of</strong> Pediatric and<br />

Adolescent Medicine, Rochester, MN, Robert Vierkant,<br />

Senior Statistician, Mayo Clinic, Division <strong>of</strong> Biostatistics,<br />

Rochester, MN, Gregory Poland, Pr<strong>of</strong>essor <strong>of</strong> Medicine, Mayo<br />

Clinic, Department <strong>of</strong> Internal Medicine, Rochester, MN<br />

The humoral and cellular immune responses to measles virus<br />

(MV) are genetically influenced. We hypothesized that the<br />

antigen-presenting function <strong>of</strong> HLA molecules could play a role<br />

in the variability in measles-specific T cell memory responses in

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!